Tasigna 200Mg Capsule
Doctors use Tasigna 200Mg Capsule in the treatment of some kinds of chronic myeloid leukemia (CML). The drug belongs to the group of medicines which are called kinase inhibitors. It functions by reducing the action of protein that helps in the multiplication of cancer cells, as a result the drug controls the spread of cancer.
The drug is available in the form of a capsule and should be taken before a meal, about 2 times in a day. The drug works best if the doses are taken after every 12 hours. The capsule should be swallowed entirely. Crushing or chewing it will make it less effective.
While you are taking Tasigna 200Mg Capsule, avoid eating grapefruit or drinking its juice, primarily because it may hinder with the effectiveness of the drug.
Some common side effects that have been reported by patients using are gas, vomiting, constipation, diarrhea, heartburn, nausea, sweating during the night, muscle cramps, dizziness and headache. These side effects mostly disappear with time. If you do experience some severe side effects like problems with breathing, appearance of blood in the urine, sore throat accompanied with a fever and shivering, pain in the stomach or sudden weakness, seek medical aid immediately.
Chronic Myeloid Leukaemia
Is It safe with alcohol?There is no data available. Please consult doctor before consuming the drug.
Are there any pregnancy warnings?There is no data available. Please consult doctor before consuming the drug.
Are there any breast-feeding warnings?There is no data available. Please consult doctor before consuming the drug.
Is it safe to drive while on this medicine?There is no data available. Please consult doctor before consuming the drug.
Does this affect kidney function?There is no data available. Please consult doctor before consuming the drug.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
Are there any missed dose instructions?If you miss a dose of Nilotinib, skip it and continue with your normal schedule. Do not double the dose.
This medication works by regulating myelogenous leukaemia by blocking the tyrosine kinase activity of the BCR-ABL protein. It works by blocking TEL-platelet-derived growth factor receptor-beta and FIP1-like-1-PDGFRalpha. AMN107 also blocks the c-Kit receptor kinase, along with D816V-mutated form of KIT.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.